Zeitschrift für Kardiologie

, Volume 94, Issue 11, pp 761–766 | Cite as

Hypereosinophilic syndrome associated with acute necrotizing myocarditis and cardiomyopathy

  • M. Huntgeburth
  • M. Lindner
  • J. W. U. Fries
  • U. C. Hoppe


We report the rare case of a 55-year-old female with massive eosinophilic myocarditis and severe, however reversible, impairment of left ventricular function. The patient presented with reduced physical condition, progressive dyspnea on exertion and peripheral edema. The white blood count revealed a leukocytosis and markedly elevated peripheral blood eosinophilics (48.8%). An endomyocardial biopsy demonstrated massive myocardial infiltration with eosinophilic granulocytes and necrosis. The symptoms and laboratory parameters indicate the presence of a hypereosinophilic syndrome. The differential diagnosis of a Churg-Strauss syndrome is discussed. Medical heart failure treatment according to international guidelines and an immunosuppressive treatment with prednisolone (Decortin H® 1.5 mg/kgBW) were initiated. This therapy led to a dramatic reduction of the eosinophilic granulocyte count and normalization of the peripheral blood count, which correlated with a significant improvement of clinical symptoms. Consistently, an increase of left-ventricular function was observed. Upon successive dose reduction to a maintenance dosage of 10 mg prednisolone, the patient’s clinical status and peripheral blood count remained stable.

Key words

Eosinophilia idiopathic hypereosinophilic syndrome myocarditis cardiomyopathy endomyocardial biopsy steroids 

Hypereosinophiles Syndrom mit akut nekrotisierender Myokarditis und Kardiomyopathie


Wir berichten über eine 55-jährige Patientin mit einer ausgeprägten eosinophilen Myokarditis und hochgradig eingeschränkter linksventrikulärer Pumpfunktion. Klinisch manifestierte sich die Erkrankung mit reduziertem Allgemeinzustand, zunehmender Belastungsdyspnoe und peripheren Ödemen. Im Blutbild fand sich eine Leukozytose mit ausgeprägter peripherer Eosinophilie (48,8%). Eine endomyokardiale Biopsie zeigte eine massive Infiltration des Myokards mit eosinophilen Granulozyten und Nekrosen. Die Symptome und Laborparameter sprechen am ehesten für ein hypereosinophiles Syndrom. Die Differentialdiagnose eines Churg-Strauss-Syndroms wird diskutiert. Es wurde eine leitliniengerechte medikamentöse Herzinsuffizienztherapie sowie immunsuppressive Therapie mit Prednisolon (Decortin H®, 1,5 mg/kgKG) eingeleitet. Darunter lies sich eine rasche Reduktion der eosinophilen Granulozyten mit Normalisierung des peripheren Blutbildes beobachten, was mit einer deutlichen Verbesserung der klinischen Symptomatik korrelierte. Insbesondere war eine signifikante Zunahme der linksventrikulären Pumpfunktion zu beobachten. Nach langsamer Dosisreduktion auf eine Erhaltungsdosis von 10 mg Prednisolon blieben das klinische Beschwerdebild und Blutbild im Verlauf stabil.


Eosinophilie idiopathisches hypereosinophiles Syndrom Myokarditis Kardiomyopathie Endomyokardiale Biopsie Steroide 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arima M, Kanoh T, Yamasaki A, Matsuda S, Kasuya H, Sunayama S, Kawai S, Okada R (1998) Eosinophilic myocarditis associated with toxicodermia caused by phenobarbital. Jpn Circ J 62(2):132–135CrossRefPubMedGoogle Scholar
  2. 2.
    Bain B (2004) The idiopathic hypereosinophilic syndrome and eosinophilic leukemias. Haematologica 89 (2):133–137PubMedGoogle Scholar
  3. 3.
    Brito-Babapulle F (2003) The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol 121(2):203–223CrossRefPubMedGoogle Scholar
  4. 4.
    Churg A (2001) Recent advances in the diagnosis of Churg-Strauss syndrome. Mod Pathol 14(12):1284–1293CrossRefPubMedGoogle Scholar
  5. 5.
    Churg A, Brallas M, Cronin SR, Churg J (1995) Formes frustes of Churg-Strauss syndrome. Chest 108 (2):320–323PubMedGoogle Scholar
  6. 6.
    Chusid MJ, Dale DC, West BC, Wolff SM (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54(1):1–27PubMedGoogle Scholar
  7. 7.
    Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348(13):1201–1214CrossRefPubMedGoogle Scholar
  8. 8.
    Corradi D, Vaglio A, Maestri R, Legname V, Leonardi G, Bartoloni G, Buzio C (2004) Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol 35(9):1160–1163CrossRefPubMedGoogle Scholar
  9. 9.
    deMello DE, Liapis H, Jureidini S, Nouri S, Kephart GM, Gleich GJ (1990) Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med 323(22):1542–1545PubMedGoogle Scholar
  10. 10.
    Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98(1):76–85PubMedGoogle Scholar
  11. 11.
    Fenoglio JJ Jr, McAllister HA Jr, Mullick FG (1981) Drug related myocarditis. I. Hypersensitivity myocarditis. Hum Pathol 12(10):900–907PubMedGoogle Scholar
  12. 12.
    Gleich GJ, Leiferman KM, Pardanani A, Tefferi A, Butterfield JH (2002) Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 359(9317):1577–1578CrossRefPubMedGoogle Scholar
  13. 13.
    Guillevin L, Fain O, Lhote F, Jarrousse B, Le Thi Huong D, Bussel A, Leon A (1992) Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum 35(2):208–215PubMedGoogle Scholar
  14. 14.
    Hirasawa M, Deguchi H, Ukimura A, Kitaura Y (2003) Immunologic interaction between infiltrating eosinophils and T lymphocytes in murine spontaneous eosinophilic myocarditis. Int Arch Allergy Immunol 130(1):73–81CrossRefPubMedGoogle Scholar
  15. 15.
    Hoppe UC, Erdmann E (2001) Guidelines for the treatment of chronic heart failure. Issued by the Executive Committee of the German Society of Cardiology—Heart and Circulation Research, compiled on behalf of the Commission of Clinical Cardiology in cooperation with Pharmaceutic Commission of the German Physicians’ Association. Z Kardiol 90(3):218–237CrossRefPubMedGoogle Scholar
  16. 16.
    Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr (2001) ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 104(24):2996–3007PubMedGoogle Scholar
  17. 17.
    Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348(20):2007–2018CrossRefPubMedGoogle Scholar
  18. 18.
    Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094–1100PubMedGoogle Scholar
  19. 19.
    Morita H, Kihara T, Tatsumi Y, Kitano Y, Sagami S (1992) Allergic granulomatosis and angiitis of Churg-Strauss. A case of high serum level of eosinophil cationic protein. Acta Derm Venereol 72(3):201–202PubMedGoogle Scholar
  20. 20.
    Nakagawa C, Sakaguchi Y, Nakajima T, Kawamoto A, Uemura S, Fujimoto S, Hashimoto T, Dohi K, Shirai T (1999) A case of eosinophilic myocarditis complicated by Kimura’s disease (eosinophilic hyperplastic lymphogranuloma) and erythroderma. Jpn Circ J 63(2):141–144CrossRefPubMedGoogle Scholar
  21. 21.
    Noth I, Strek ME, Leff AR (2003) Churg-Strauss syndrome. Lancet 361 (9357):587–594CrossRefPubMedGoogle Scholar
  22. 22.
    Olsen EG, Spry C (1985) Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis 27(4):241–254CrossRefPubMedGoogle Scholar
  23. 23.
    Pardanani A, Reeder T, Porrata LF, Li CY, Tazelaar HD, Baxter EJ, Witzig TE, Cross NC, Tefferi A (2003) Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood 101(9):3391–3397CrossRefPubMedGoogle Scholar
  24. 24.
    Pardanani A, Tefferi A (2004) Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders. Leuk Res 28(Suppl 1):S47–52CrossRefPubMedGoogle Scholar
  25. 25.
    Remme WJ, Swedberg K (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22(17):1527–1560CrossRefPubMedGoogle Scholar
  26. 26.
    Tuggey JM, Hosker HS (2000) Churg-Strauss syndrome associated with montelukast therapy. Thorax 55(9):805–806CrossRefPubMedGoogle Scholar
  27. 27.
    Weller PF, Plaut M, Taggart V, Trontell A (2001) The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol 108(2):175–183CrossRefPubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2005

Authors and Affiliations

  • M. Huntgeburth
    • 1
  • M. Lindner
    • 1
  • J. W. U. Fries
    • 2
  • U. C. Hoppe
    • 1
  1. 1.Klinik III für Innere MedizinUniversität zu KölnCologneGermany
  2. 2.Universität zu Köln, Institut für PathologieCologneGermany

Personalised recommendations